Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/79797
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorFernández-Moreno, Miguel Ángel-
dc.contributor.authorBornstein, Belén-
dc.contributor.authorPetit, Nathalie-
dc.contributor.authorGaresse, Rafael-
dc.date.accessioned2013-07-17T10:14:22Z-
dc.date.available2013-07-17T10:14:22Z-
dc.date.issued2000-
dc.identifierdoi: 10.1006/mgme.2000.3083-
dc.identifierissn: 1096-7192-
dc.identifiere-issn: 1096-7206-
dc.identifier.citationMolecular Genetics and Metabolism 71(3): 481-495 (2000)-
dc.identifier.urihttp://hdl.handle.net/10261/79797-
dc.description.abstractMitochondria are with very few exceptions ubiquitous organelles in eukaryotic cells where they are essential for cell life and death. Mitochondria play a central role not only in a variety of metabolic pathways including the supply of the bulk of cellular ATP through oxidative phosphorylation (OXPHOS), but also in complex processes such as development, apoptosis, and aging. Mitochondria contain their own genome that is replicated and expressed within the organelle. It encodes 13 polypeptides all of them components of the OXPHOS system, and thus, the integrity of the mitochondrial DNA (mtDNA) is critical for cellular energy supply. In the past 12 years more than 50 point mutations and around 100 rearrangements in the mtDNA have been associated with human diseases. Also in recent years, several mutations in nuclear genes that encode structural or regulatory factors of the OXPHOS system or the mtDNA metabolism have been described. The development of increasingly powerful techniques and the use of cellular and animal models are opening new avenues in the study of mitochondrial medicine. The detailed molecular characterization of the effects produced by different mutations that cause mitochondrial cytopathies will be critical for designing rational therapeutic strategies for this group of devastating diseases. (C) 2000 Academic Press.-
dc.description.sponsorshipThis work was supported by grants from Comunidad Autónoma de Madrid (003/97) and from the DGICYT (Ministerio de Educación y Ciencia, Spain; PB97-0034).-
dc.language.isoeng-
dc.publisherElsevier-
dc.rightsclosedAccess-
dc.titleThe pathophysiology of mitochondrial biogenesis: Towards four decades of mitochondrial DNA research-
dc.typeartículo-
dc.identifier.doi10.1006/mgme.2000.3083-
dc.date.updated2013-07-17T10:14:22Z-
dc.description.versionPeer Reviewed-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeartículo-
item.languageiso639-1en-
item.grantfulltextnone-
Aparece en las colecciones: (IIBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

16
checked on 12-abr-2024

WEB OF SCIENCETM
Citations

15
checked on 21-feb-2024

Page view(s)

296
checked on 17-abr-2024

Download(s)

122
checked on 17-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.